Financial incentives for smoking cessation in low-income smokers: Study protocol for a randomized controlled trial

Trials

Volumn 13, Issue , 2012, Pages

  Etter, Jean François ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Financial incentives; Smoking; Smoking cessation

Indexed keywords

CARBON MONOXIDE; COTININE; THIOCYANATE;

ARTICLE; BODY WEIGHT; CONTROLLED STUDY; E-MAIL; FINANCE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMAN; INTERNET; LOWEST INCOME GROUP; MOTIVATION; PATIENT COUNSELING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REWARD; SALIVA; SELF HELP; SELF REPORT; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; SWITZERLAND; TELECONSULTATION;

COUNSELING; HUMANS; MOTIVATION; PAMPHLETS; POVERTY; RECURRENCE; RESEARCH DESIGN; REWARD; SMOKING; SMOKING CESSATION; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862507174     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-88     Document Type: Article

References (47)

1. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362:847-852. 10.1016/S0140-6736(03)14338-3, 13678970.
2. Huisman M, Kunst AE, Mackenbach JP. Inequalities in the prevalence of smoking in the European Union: comparing education and income. Prev Med 2005, 40:756-764. 10.1016/j.ypmed.2004.09.022, 15850876.
3. Etter JF, Perneger TV. Effectiveness of a computer-tailored smoking cessation program: a randomized trial. Arch Intern Med 2001, 161:2596-2601. 10.1001/archinte.161.21.2596, 11718591.
4. Townsend J, Roderick P, Cooper J. Cigarette smoking by socioeconomic group, sex, and age: effects of price, income, and health publicity. BMJ 1994, 309:923-927. 10.1136/bmj.309.6959.923, 2541176, 7950662.
5. Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560. 10.1111/j.1360-0443.2006.01581.x, 17034434.
6. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009, 360:699-709. 10.1056/NEJMsa0806819, 19213683.
7. Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203. 10.1111/j.1360-0443.2006.01311.x, 16445548.
8. Cahill K, Perera R. Competitions and incentives for smoking cessation. Cochrane Database Syst Rev 2011, (4):CD004307.
9. Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA 2007, 298:2415-2417. 10.1001/jama.298.20.2415, 18042920.
10. Jeanrenaud C, Vitale S, Priez F. Le coût social de la consommation de tabac en Suisse 1998, Neuchâtel: Institut de Recherches Economiques.
11. Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend 2000, 58:9-25. 10.1016/S0376-8716(99)00071-X, 10669051.
12. Higgins ST, Petry NM. Contingency management. Incentives for sobriety. Alcohol Res Health 1999, 23:122-127.
13. Stitzer ML, Vandrey R. Contingency management: utility in the treatment of drug abuse disorders. Clin Pharmacol Ther 2008, 83:644-647. 10.1038/sj.clpt.6100508, 18305456.
14. Higgins ST, Washio Y, Heil SH, Solomon LJ, Gaalema DE. Higgins TM 2011, Bernstein IM: Financial incentives for smoking cessation among pregnant and newly postpartum women. Prev Med, [Epub ahead of print].
15. Volpp KG, Levy AG, Asch DA, Berline JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev 2006, 15:12-18. 10.1158/1055-9965.EPI-05-0314, 16434580.
16. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W. Smoking cessation in methadone maintenance. Addiction 2002, 97:1317-1328. 10.1046/j.1360-0443.2002.00221.x, 12359036.
17. Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006, 15:280-285. 10.1136/tc.2005.015487, 2563611, 16885576.
18. Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav 2008, 33:1516-1520. 10.1016/j.addbeh.2008.05.012, 2577779, 18706769.
19. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995, 15:369-390. 10.1111/j.1539-6924.1995.tb00330.x, 7604170.
20. Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making 2002, Suppl 5:S26-S37.
21. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, Raftery JP, Aveyard PN, Hyde CJ, Barton PM. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002, 6:1-245.
22. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006, 31:52-61. 10.1016/j.amepre.2006.03.012, 16777543.
23. Heil SH, Higgins ST, Bernstein IM, Solomon LJ, Rogers RE, Thomas CS, Badger GJ, Lynch ME. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 2008, 103:1009-1018. 10.1111/j.1360-0443.2008.02237.x, 2731575, 18482424.
24. Sindelar JL, Olmstead TA, Peirce JM. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471. 10.1111/j.1360-0443.2007.01913.x, 3072844, 17645428.
25. Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost-effectiveness of adding contingency management. Addiction 2007, 102:309-316. 10.1111/j.1360-0443.2006.01689.x, 17222286.
26. Curry S, Wagner EH, Grothaus LC. Intrinsic and extrinsic motivation for smoking cessation. J Consult Clin Psychol 1990, 58:310-316.
27. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res 2008, 10:607-612. 10.1080/14622200801978680, 18418783.
28. Montalto NJ, Wells WO. Validation of self-reported smoking status using saliva cotinine: a rapid semiquantitative dipstick method. Cancer Epidemiol Biomarkers Prev 2007, 16:1858-1862. 10.1158/1055-9965.EPI-07-0189, 17855706.
29. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 2005, 100:159-167. 10.1111/j.1360-0443.2004.00957.x, 15679745.
30. Etter JF, Vu Duc T, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 2000, 151:251-258. 10.1093/oxfordjournals.aje.a010200, 10670549.
31. Haley NJ, Axelrad CM, Tilton KA. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am J Public Health 1983, 73:1204-1207. 10.2105/AJPH.73.10.1204, 1651081, 6614277.
32. Vogt TM, Selvin S, Widdowson G, Hulley SB. Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health 1977, 67:545-549. 10.2105/AJPH.67.6.545, 1653665, 869087.
33. Office Cantonal de la Statistique (OCSTAT) Répartition des contribuables et du revenu annuel brut, selon la classe de revenu 2006, Genève: OCSTAT, Office Cantonal de la Statistique (OCSTAT).
34. Office Fédéral de la Statistique Internet dans les ménages en Suisse - Résultats de l'enquête Omnibus TIC 2010 2012, Neuchâtel: Office Fédéral de la Statistique, Office Fédéral de la Statistique.
35. Long JA, Helweg-Larsen M, Volpp KG. Patient opinions regarding 'pay for performance for patients'. J Gen Intern Med 2008, 23:1647-1652. 10.1007/s11606-008-0739-1, 2533373, 18663540.
36. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004, 99:29-38. 10.1111/j.1360-0443.2004.00540.x, 14678060.
37. Rowan-Szal G, Joe GW, Chatham LR, Simpson DD. A simple reinforcement system for methadone clients in a community-based treatment program. J Subst Abuse Treat 1994, 11:217-223. 10.1016/0740-5472(94)90078-7, 8072049.
38. Roll JM, Higgins ST, Badger GJ. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal 1996, 29:495-504. 10.1901/jaba.1996.29-495, 1284006, 8995832.
39. Etter JF. Comparing the efficacy of two Internet-based, computer-tailored smoking cessation programs: a randomized trial. J Med Internet Res 2005, 7:e2. 10.2196/jmir.7.1.e2, 1550632, 15829474.
40. Etter JF. Informing smokers about additives in cigarettes a randomized trial. Patient Educ Counsel 2007, 66:188-191.
41. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003, 5:13-25.
42. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005, 100:299-303. 10.1111/j.1360-0443.2004.00995.x, 15733243.
43. Dillman DA. Mail and Internet surveys: the tailored design method 2000, New York: John Wiley & Sons.
44. Etter JF, Cornuz J, Huguelet P, Perneger TV. Pre-cessation treatment with nicotine replacement therapy: a randomized trial. Arch Intern Med 2009, 169:11.
45. Etter JF. Comparing computer-tailored, internet-based smoking cessation counseling reports with generic, untailored reports: a randomized trial. J Health Commun 2009, 14:646-657. 10.1080/10810730903204254, 19851916.
46. Etter JF, Huguelet P, Perneger TV, Cornuz J. Nicotine gum treatment before smoking cessation: a randomized trial. Arch Intern Med 2009, 169:1028-1034. 10.1001/archinternmed.2009.12, 19506172.
47. Etter JF, Laszlo E, Zellweger JP, Perrot C, Perneger TV. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. J Clin Psychopharmacol 2002, 22:487-495. 10.1097/00004714-200210000-00008, 12352272.